These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36536076)

  • 41. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway.
    Yan X; Liu DF; Zhang XY; Liu D; Xu SY; Chen GX; Huang BX; Ren WZ; Wang W; Fu SP; Liu JX
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
    Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
    Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation.
    Chen CM; Yen CY; Chen WL; Lin CH; Wu YR; Chang KH; Lee-Chen GJ
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494411
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection.
    Sharma N; Sharma S; Nehru B
    Inflammopharmacology; 2017 Jun; 25(3):351-368. PubMed ID: 28409389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.
    Huang B; Liu J; Ju C; Yang D; Chen G; Xu S; Zeng Y; Yan X; Wang W; Liu D; Fu S
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RIPK1 Regulates Microglial Activation in Lipopolysaccharide-Induced Neuroinflammation and MPTP-Induced Parkinson's Disease Mouse Models.
    Kim DY; Leem YH; Park JS; Park JE; Park JM; Kang JL; Kim HS
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
    Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
    FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions.
    Zhang F; Shi JS; Zhou H; Wilson B; Hong JS; Gao HM
    Mol Pharmacol; 2010 Sep; 78(3):466-77. PubMed ID: 20554604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isoliquiritigenin inhibits microglia-mediated neuroinflammation in models of Parkinson's disease via JNK/AKT/NFκB signaling pathway.
    Bai Y; Zhou J; Zhu H; Tao Y; Wang L; Yang L; Wu H; Huang F; Shi H; Wu X
    Phytother Res; 2023 Mar; 37(3):848-859. PubMed ID: 36484427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Magnesium Lithospermate B Suppresses Lipopolysaccharide-Induced Neuroinflammation in BV2 Microglial Cells and Attenuates Neurodegeneration in Lipopolysaccharide-Injected Mice.
    Tai Y; Qiu Y; Bao Z
    J Mol Neurosci; 2018 Jan; 64(1):80-92. PubMed ID: 29196883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A tetramethoxychalcone from Chloranthus henryi suppresses lipopolysaccharide-induced inflammatory responses in BV2 microglia.
    Luo XL; Liu SY; Wang LJ; Zhang QY; Xu P; Pan LL; Hu JF
    Eur J Pharmacol; 2016 Mar; 774():135-43. PubMed ID: 26852953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of Sonic hedgehog signal by Purmorphamine, in a mouse model of Parkinson's disease, protects dopaminergic neurons and attenuates inflammatory response by mediating PI3K/AKt signaling pathway.
    Shao S; Wang GL; Raymond C; Deng XH; Zhu XL; Wang D; Hong LP
    Mol Med Rep; 2017 Aug; 16(2):1269-1277. PubMed ID: 28627590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson's disease mouse models.
    Lee YY; Park JS; Leem YH; Park JE; Kim DY; Choi YH; Park EM; Kang JL; Kim HS
    J Neuroinflammation; 2019 Dec; 16(1):246. PubMed ID: 31791357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel synthetic peptide SVHRSP attenuates dopaminergic neurodegeneration by inhibiting NADPH oxidase-mediated neuroinflammation in experimental models of Parkinson's disease.
    Zhang X; Tu D; Li S; Li N; Li D; Gao Y; Tian L; Liu J; Zhang X; Hong JS; Hou L; Zhao J; Wang Q
    Free Radic Biol Med; 2022 Aug; 188():363-374. PubMed ID: 35760232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HCH6-1, an antagonist of formyl peptide receptor-1, exerts anti-neuroinflammatory and neuroprotective effects in cellular and animal models of Parkinson's disease.
    Wang HL; Cheng YC; Yeh TH; Liu HF; Weng YH; Chen RS; Chen YC; Lu JC; Hwang TL; Wei KC; Liu YC; Wang YT; Hsu CC; Chiu TJ; Chiu CC
    Biochem Pharmacol; 2023 Jun; 212():115524. PubMed ID: 37001680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Potent PDE10A Inhibitor MP-10 (PF-2545920) Suppresses Microglial Activation in LPS-Induced Neuroinflammation and MPTP-Induced Parkinson's Disease Mouse Models.
    Kim DY; Park JS; Leem YH; Park JE; Kim HS
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):470-482. PubMed ID: 32671618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of microglia induces symptoms of Parkinson's disease in wild-type, but not in IL-1 knockout mice.
    Tanaka S; Ishii A; Ohtaki H; Shioda S; Yoshida T; Numazawa S
    J Neuroinflammation; 2013 Dec; 10():143. PubMed ID: 24289537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of Nur77 in microglia attenuates proinflammatory mediators production and protects dopaminergic neurons from inflammation-induced cell death.
    Liu TY; Yang XY; Zheng LT; Wang GH; Zhen XC
    J Neurochem; 2017 Feb; 140(4):589-604. PubMed ID: 27889907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LRRK2 regulates ferroptosis through the system Xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease.
    Zheng Z; Zhang S; Liu X; Wang X; Xue C; Wu X; Zhang X; Xu X; Liu Z; Yao L; Lu G
    J Cell Physiol; 2024 May; 239(5):e31250. PubMed ID: 38477420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson's Disease.
    De Araújo FM; Frota AF; de Jesus LB; Macedo TC; Cuenca-Bermejo L; Sanchez-Rodrigo C; Ferreira KMS; de Oliveira JVR; de Fatima Dias Costa M; Segura-Aguilar J; Costa SL; Herrero MT; Silva VDA
    Cell Mol Neurobiol; 2023 Jan; 43(1):265-281. PubMed ID: 34988761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.